DUBLIN, May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the upcoming launch of a new clinical study relevant to the use of Qwo ® (collagenase clostridium histolyticum ...
DUBLIN, March 2, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) has kicked off a series of more than 200 patient events that will be held across the United States as part of Butt First, a ...
Endo International (OTCPK:ENDPQ) will eliminate 90 positions in the wake of a decision to end the production and sales of Qwo, its treatment for cellulite in female buttocks. The company said that it ...